1. Repository of OAI
  2. ΑΠΟΘΕΤΗΡΙΟ "ΟΛΥΜΠΙΑΣ"
  3. Σχολή Επιστημών Υγείας
  4. Τμήμα Ιατρικής
  5. Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ
Ελληνικά   English  
Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/23044
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZagorianakou, N.en
dc.contributor.authorStefanou, D.en
dc.contributor.authorMakrydimas, G.en
dc.contributor.authorZagorianakou, P.en
dc.contributor.authorBriasoulis, E.en
dc.contributor.authorKaravasilis, V.en
dc.contributor.authorPavlidis, N.en
dc.contributor.authorAgnantis, N. J.en
dc.date.accessioned2015-11-24T19:30:13Z-
dc.date.available2015-11-24T19:30:13Z-
dc.identifier.issn1699-5848-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/23044-
dc.rightsDefault Licence-
dc.subjectAdolescenten
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectCarcinoma/*chemistry/diagnosis/pathologyen
dc.subjectCell Differentiation/geneticsen
dc.subjectCell Proliferationen
dc.subjectCystadenoma, Mucinous/chemistry/diagnosis/pathologyen
dc.subjectCystadenoma, Serous/chemistry/diagnosis/pathologyen
dc.subjectDiagnosis, Differentialen
dc.subjectDisease Progressionen
dc.subjectFemaleen
dc.subjectGene Expression Regulation, Neoplasticen
dc.subjectHumansen
dc.subjectImmunohistochemistryen
dc.subjectMetallothionein/*analysis/genetics/physiologyen
dc.subjectMiddle Ageden
dc.subjectOvarian Neoplasms/*chemistry/diagnosis/pathologyen
dc.subjectTumor Markers, Biological/analysisen
dc.subjectTumor Suppressor Protein p53/analysis/genetics/physiologyen
dc.titleClinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumorsen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/16437378-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2006-
heal.abstractMetallothioneins (MTs) are a family of cystein-rich metal-binding proteins, which are expressed in normal cells during fetal and postnatal life but also in a variety of human neoplasms. MT expression in human tumors has been linked to resistance to anticancer drugs and differentiation and progression in some types of tumors. This study examined the immunohistochemical expression of MTs in benign, borderline and malignant tumors of ovarian surface epithelium and the possible correlations with clinicopathological parameters and survival. A total of 87 cases with diagnosis of ovarian surface epithelial tumors were included. Specifically, 21 cases of benign cystadenomas (11 serous and 10 mucinous), 14 borderline (low malignant potential tumors, 8 mucinous and 6 serous) and 52 cases of ovarian cancer were analysed. Immunohistochemical expression of MT (cut-off level > 10% of tumor cells) was clearly associated with malignancy. A statistically significant correlation was found between the expression of MT in cancer cases and benign tumors (p < 0.0001) and cancer cases and borderline tumors p = 0.003. In cancer cases a difference was observed between grade I and III (p = 0.002). There was no correlation of MT overexpression with survival in the small number of ovarian carcinoma patients where it was analysed. MT constitutes a marker that characterizes aggressiveness and a high malignant potential in ovarian epithelial tumors. In diagnostic problems MT may help distinguish between benign, borderline and malignant tumors.en
heal.journalNameHistology and Histopathologyen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Show simple item record
Files in This Item:
File Description SizeFormat 
Briasoulis-2006-clinicopathological study of.pdf655.68 kBAdobe PDFView/Open    Request a copy
Show simple item record  


This item is licensed under a Creative Commons License Creative Commons